In acute myeloid leukemia (AML), the expression of miR-34c-5p promotes eradication of AML LSCs through induced LSCs senescence via p53-p21Cip1-CDK/Cyclin or p53-independent CDK/Cyclin pathways16. The gene discussed is TP53; the disease is acute myeloid leukemia.